0,887  0,004  Caspase 9 stimulant
0,797  0,005  Sensitization
0,791  0,017  Antiinflammatory
0,786  0,018  Apoptosis agonist
0,669  0,005  UGT1A4 substrate
0,672  0,012  Antihypercholesterolemic
0,655  0,018  TNF expression inhibitor
0,653  0,024  Antineoplastic (lung cancer)
0,636  0,029  Antineoplastic (breast cancer)
0,604  0,018  Cholesterol antagonist
0,601  0,024  Antileukemic
0,581  0,013  Antineoplastic (pancreatic cancer)
0,564  0,017  Antipruritic, allergic
0,577  0,034  Transcription factor NF kappa B inhibitor
0,556  0,015  UGT1A9 substrate
0,540  0,016  Cardiovascular analeptic
0,528  0,009  UGT1A1 substrate
0,520  0,014  Nitric oxide antagonist
0,511  0,007  UGT1A3 substrate
0,520  0,024  Antineoplastic (ovarian cancer)
0,502  0,010  Antihypoxic
0,518  0,029  Prostate cancer treatment
0,495  0,012  UGT2B4 substrate
0,503  0,021  Hepatic disorders treatment
0,484  0,005  UGT2B7 substrate
0,504  0,028  Respiratory analeptic
0,496  0,021  Caspase 3 stimulant
0,494  0,020  Chemopreventive
0,471  0,004  Antiinfertility, female
0,486  0,023  Lipoprotein disorders treatment
0,467  0,009  Hair growth stimulant
0,470  0,012  Antineoplastic (liver cancer)
0,483  0,026  Antineoplastic (melanoma)
0,462  0,007  Prostate disorders treatment
0,478  0,024  AR expression inhibitor
0,458  0,008  Interferon gamma antagonist
0,454  0,005  UGT2B15 substrate
0,455  0,009  Prostatic (benign) hyperplasia treatment
0,465  0,024  Antineoplastic (glioma)
0,457  0,017  UGT1A6 substrate
0,459  0,027  Antipsoriatic
0,440  0,008  Antiacne
0,444  0,016  Antineoplastic (endocrine cancer)
0,437  0,010  Contraceptive
0,423  0,004  UGT2B9 substrate
0,424  0,008  Antipruritic, non-allergic
0,418  0,004  Contraceptive female
0,442  0,030  Antineoplastic (cervical cancer)
0,429  0,017  Antineoplastic enhancer
0,448  0,037  Bone diseases treatment
0,439  0,029  Chemoprotective
0,418  0,011  Non-steroidal antiinflammatory agent
0,432  0,031  NOS3 expression inhibitor
0,440  0,045  Antineoplastic (colorectal cancer)
0,415  0,023  Hypolipemic
0,419  0,029  NOS2 expression inhibitor
0,393  0,006  Neurotrophic factor enhancer
0,431  0,044  Antineoplastic (colon cancer)
0,412  0,025  Antipyretic
0,385  0,005  Cholesterol synthesis inhibitor
0,399  0,021  UDP-glucuronosyltransferase substrate
0,411  0,035  Cytotoxic
0,397  0,026  Calcium channel activator
0,390  0,020  Sodium/bile acid cotransporter inhibitor
0,423  0,057  CYP3A4 substrate
0,403  0,037  Analeptic
0,371  0,007  Gastrin inhibitor
0,423  0,064  Histamine release inhibitor
0,365  0,009  Antiviral (Influenza A)
0,410  0,059  Immunosuppressant
0,371  0,020  Anesthetic general
0,408  0,059  CYP2C19 inhibitor
0,363  0,017  Hepatoprotectant
0,385  0,041  Antiosteoporotic
0,373  0,036  Antineoplastic (multiple myeloma)
0,346  0,010  Interleukin 6 antagonist
0,359  0,031  Vascular (periferal) disease treatment
0,389  0,064  Ulceration
0,343  0,020  Antiviral (Influenza)
0,369  0,047  Antineoplastic (brain cancer)
0,345  0,026  Abortion inducer
0,372  0,053  Antifungal
0,360  0,048  CYP2C19 substrate
0,345  0,034  Antiparasitic
0,328  0,018  Anesthetic
0,400  0,091  Cyclophilin D inhibitor
0,400  0,091  Antidiabetic
0,312  0,005  Aromatase inhibitor
0,356  0,050  Teratogen
0,373  0,072  CYP2C9 substrate
0,352  0,055  Apoptosis antagonist
0,344  0,050  Embryotoxic
0,359  0,068  Antiprotozoal (Plasmodium)
0,319  0,029  Growth hormone agonist
0,328  0,045  Proliferative diseases treatment
0,287  0,005  ABCA1 expression enhancer
0,311  0,029  Antihelmintic
0,320  0,042  Antineoplastic (glioblastoma multiforme)
0,342  0,066  ICAM1 expression inhibitor
0,328  0,052  Antioxidant
0,286  0,012  Antifungal enhancer
0,279  0,005  HDL-cholesterol increasing
0,320  0,046  Tumour necrosis factor alpha release inhibitor
0,292  0,023  Lipocortins synthesis antagonist
0,285  0,022  Protein-tyrosine phosphatase inhibitor
0,353  0,090  Antiprotozoal
0,328  0,066  12-Lipoxygenase inhibitor
0,261  0,004  Antiviral (Coronavirus)
0,261  0,004  Antiviral (SARS coronavirus)
0,305  0,052  Antiprotozoal (Leishmania)
0,257  0,010  Farnesoid X receptor antagonist
0,247  0,005  TRPA1 agonist
0,250  0,009  Androgen antagonist
0,243  0,004  Ornithine decarboxylase inhibitor
0,247  0,008  Potassium channel (Ca-activated) activator
0,247  0,017  Protein-tyrosine phosphatase 1B inhibitor
0,235  0,005  Potassium channel large-conductance Ca-activated activator
0,290  0,061  DNA damaging
0,237  0,009  Arachidonic acid antagonist
0,295  0,068  Hypoxia-inducible factor 1 alpha inhibitor
0,243  0,015  UGT2B10 substrate
0,236  0,012  SULT1A1 substrate
0,327  0,104  Atherosclerosis treatment
0,233  0,012  UGT2B1 substrate
0,226  0,005  CDC25A inhibitor
0,222  0,004  5-Alpha-reductase inhibitor
0,239  0,024  Heat shock protein 90 antagonist
0,234  0,021  Adenylate cyclase inhibitor
0,236  0,028  LDLR expression enhancer
0,258  0,051  Antiparkinsonian, rigidity relieving
0,236  0,030  Protein kinase stimulant
0,234  0,031  Melanin inhibitor
0,254  0,054  Carcinogenic
0,249  0,050  RNA-directed DNA polymerase inhibitor
0,215  0,017  Retinoprotector
0,317  0,120  15-Lipoxygenase inhibitor
0,261  0,064  Cardiodepressant
0,278  0,082  Cardioprotectant
0,257  0,062  Antineoplastic (sarcoma)
0,202  0,010  Pregnane X receptor agonist
0,250  0,060  Antiulcerative
0,280  0,092  CYP3A4 inhibitor
0,197  0,010  Actinic keratosis treatment
0,259  0,074  Antineoplastic (renal cancer)
0,222  0,037  Diuretic
0,255  0,074  Hypoglycemic
0,266  0,087  CYP1A2 substrate
0,218  0,040  Antiviral (Herpes)
0,180  0,005  Acetyl-CoA transferase inhibitor
0,295  0,120  Antiobesity
0,271  0,097  Interleukin 2 agonist
0,304  0,132  Antibacterial
0,253  0,084  Transcription factor STAT inhibitor
0,174  0,006  Glutamate release inhibitor
0,187  0,021  Adenylate cyclase stimulant
0,250  0,083  Transcription factor STAT3 inhibitor
0,195  0,033  SULT1A3 substrate
0,228  0,067  Antihypertriglyceridemic
0,159  0,003  Retinoid X alpha receptor agonist
0,243  0,088  5 Hydroxytryptamine uptake stimulant
0,206  0,053  Muscle relaxant
0,201  0,048  Antipruritic
0,210  0,058  P-glycoprotein inhibitor
0,156  0,005  Anticholelithogenic
0,227  0,076  Antineoplastic (lymphoma)
0,213  0,062  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,161  0,014  Inducible nitric-oxide synthase inhibitor
0,180  0,033  Antihyperlipoproteinemic
0,159  0,014  Anabolic
0,148  0,003  Heme oxygenase stimulant
0,171  0,026  Nav1.1 sodium channel blocker
0,154  0,009  3C-Like protease (SARS coronavirus) inhibitor
0,240  0,096  Spasmolytic
0,255  0,112  Antineoplastic (osteosarcoma)
0,226  0,082  Antineoplastic (lymphocytic leukemia)
0,178  0,036  DNA polymerase I inhibitor
0,153  0,014  UGT2B11 substrate
0,190  0,051  Phospholipase C inhibitor
0,169  0,034  Antihemorrhagic
0,162  0,028  Choleretic
0,185  0,051  Phospholipase A2 inhibitor
0,225  0,091  Antineoplastic (non-small cell lung cancer)
0,159  0,025  Sulfotransferase substrate
0,196  0,063  VEGF expression inhibitor
0,152  0,019  Potassium channel activator
0,140  0,009  Bile acid receptor antagonist
0,133  0,003  Retinoid X receptor agonist
0,234  0,104  Antidiabetic (type 2)
0,178  0,048  Skeletal muscle relaxant
0,181  0,052  Acute respiratory distress syndrome (ARDS) treatment
0,167  0,039  Antieczematic
0,130  0,003  Cholesterol ester transfer protein antagonist
0,139  0,013  Estrogen receptor alpha antagonist
0,177  0,051  Antiparkinsonian, tremor relieving
0,133  0,007  Progesterone antagonist
0,176  0,052  Lipid peroxidase inhibitor
0,249  0,128  Vasodilator, peripheral
0,240  0,120  CTGF expression inhibitor
0,123  0,005  Liver X receptor alpha agonist
0,127  0,010  CDC25B inhibitor
0,129  0,012  Na+ K+ transporting ATPase inhibitor
0,185  0,069  Diabetic nephropathy treatment
0,125  0,010  Cannabinoid CB2 receptor antagonist
0,127  0,011  SULT1A2 substrate
0,157  0,043  Cyclooxygenase 3 inhibitor
0,131  0,019  Tocolytic
0,177  0,065  Toxic, respiratory center
0,123  0,013  Cushing's syndrome treatment
0,139  0,029  Estrogen antagonist
0,158  0,050  Skin whitener
0,158  0,050  Psychosexual dysfunction treatment
0,161  0,056  Hemostatic
0,125  0,020  Keratolytic
0,307  0,203  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,155  0,054  Interleukin 1 antagonist
0,173  0,072  Antineoplastic (bone cancer)
0,140  0,040  Endometrios treatment
0,123  0,024  Transcription factor NF kappa B stimulant
0,102  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,143  0,045  Interleukin 1b antagonist
0,124  0,027  Estrogen receptor beta antagonist
0,103  0,007  Liver X receptor agonist
0,104  0,008  Aldosterone antagonist
0,121  0,028  Interleukin 12 antagonist
0,098  0,005  5-Alpha-reductase 2 inhibitor
0,094  0,004  Geranyltranstransferase inhibitor
0,101  0,011  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,141  0,051  Antiviral (Hepatitis B)
0,093  0,007  RNA-directed RNA polymerase stimulant
0,155  0,069  Acaricide
0,118  0,032  Paget's disease treatment
0,095  0,011  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,156  0,073  Antimutagenic
0,142  0,058  Antiseptic
0,159  0,078  Heat shock protein 90 alpha antagonist
0,086  0,004  Liver X receptor alpha antagonist
0,135  0,054  Growth stimulant
0,097  0,018  Estrogen agonist
0,223  0,144  GST M1-1 substrate
0,200  0,121  Interleukin agonist
0,134  0,056  CC chemokine 6 receptor antagonist
0,082  0,005  Liver X receptor antagonist
0,135  0,058  Vanilloid 1 agonist
0,082  0,005  Acetyl-CoA transferase 1 inhibitor
0,181  0,105  Angiogenesis stimulant
0,167  0,091  Antirickettsial
0,105  0,031  Contraceptive male
0,092  0,018  Androgen agonist
0,200  0,128  Antituberculosic
0,080  0,010  Acetyl-CoA transferase 2 inhibitor
0,074  0,005  Alpha 1L adrenoreceptor agonist
0,242  0,173  CYP2C9 inhibitor
0,072  0,004  Retinoid X receptor antagonist
0,133  0,067  Acetylcholinesterase inhibitor
0,109  0,042  Antineoplastic antibiotic
0,092  0,026  Glycine receptor agonist
0,155  0,088  Liver fibrosis treatment
0,145  0,079  Insulin secretagoues
0,161  0,095  Sedative
0,084  0,019  Transcription factor AP-1 inhibitor
0,069  0,004  Retinoid X gamma receptor agonist
0,069  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,079  0,016  Calcium channel P-type blocker
0,126  0,063  Anesthetic local
0,072  0,009  Cholesterol esterase inhibitor
0,068  0,006  5-Alpha-reductase 1 inhibitor
0,122  0,060  Menstruation disorders treatment
0,149  0,087  Antihelmintic (Nematodes)
0,077  0,015  Postcoital contraceptive
0,254  0,193  Antiarthritic
0,069  0,009  Glucocorticoid antagonist
0,108  0,048  Nitric-oxide synthase inhibitor
0,062  0,004  Retinoid X alpha receptor antagonist
0,070  0,012  Adenylate cyclase 1 inhibitor
0,075  0,017  Lipocortins synthesis agonist
0,063  0,005  Liver X receptor beta antagonist
0,189  0,131  5 Hydroxytryptamine release stimulant
0,121  0,064  Alcohol dehydrogenase substrate
0,064  0,008  Liver X receptor beta agonist
0,118  0,063  Microtubule formation inhibitor
0,198  0,144  CYP2D6 substrate
0,218  0,165  Vasodilator, coronary
0,067  0,016  Mineralocorticoid receptor antagonist
0,068  0,017  Pregnane X receptor antagonist
0,090  0,040  Estrogen-related receptor beta agonist
0,059  0,009  Retinoic acid alpha receptor agonist
0,051  0,002  Retinoid X beta receptor antagonist
0,154  0,107  Phobic disorders treatment
0,111  0,064  Skin irritative effect
0,112  0,067  Monophenol monooxygenase inhibitor
0,138  0,094  Sigma receptor agonist
0,192  0,149  Lipoxygenase inhibitor
0,047  0,004  Retinoid X gamma receptor antagonist
0,196  0,154  Antimycobacterial
0,054  0,012  Farnesoid X receptor agonist
0,176  0,135  Immunostimulant
0,189  0,149  Antineoplastic (bladder cancer)
0,057  0,018  Estrogen receptor beta agonist
0,080  0,043  Lipase inhibitor
0,042  0,004  Retinoic acid alpha receptor antagonist
0,057  0,021  Estradiol 17 beta-dehydrogenase inhibitor
0,065  0,029  Postmenopausal disorders treatment
0,213  0,177  FMO1 substrate
0,097  0,061  Lanosterol 14 alpha demethylase inhibitor
0,077  0,042  Purinergic P2X2 antagonist
0,038  0,004  Retinoic acid receptor antagonist
0,068  0,034  Antimycoplasmal
0,039  0,006  Retinoid X beta receptor agonist
0,051  0,020  Parathyroid hormone antagonist
0,042  0,012  ATP citrate lysase inhibitor
0,044  0,016  Glucose-6-phosphate dehydrogenase inhibitor
0,106  0,078  Antitussive
0,069  0,041  Antihemophilic
0,127  0,100  Mutagenic
0,032  0,005  Retinoic acid gamma receptor agonist
0,117  0,091  Cocaine dependence treatment
0,115  0,089  Nav1.2 sodium channel blocker
0,034  0,008  Retinoic acid receptor agonist
0,064  0,039  HIV-1 integrase (Strand Transfer) inhibitor
0,179  0,154  Amyotrophic lateral sclerosis treatment
0,080  0,057  Glycine receptor antagonist
0,126  0,104  Eye irritation, high
0,032  0,010  Hedgehog signaling activator
0,050  0,029  Potassium channel Kv1.3 blocker
0,082  0,060  GABA A receptor agonist
0,139  0,119  Platelet adhesion inhibitor
0,151  0,132  Insulin sensitizer
0,087  0,069  SULT1E1 substrate
0,042  0,024  Cholesterol absorption inhibitor
0,131  0,113  Ca2+-transporting ATPase inhibitor
0,043  0,026  Hypogonadism treatment
0,060  0,043  TRPA1 antagonist
0,097  0,081  GABA receptor agonist
0,063  0,046  Hyperparathyroidism treatment
0,038  0,022  Estrogen receptor alpha agonist
0,036  0,020  HMG CoA reductase inhibitor
0,024  0,008  Retinoic acid beta receptor agonist
0,205  0,190  Stroke treatment
0,019  0,004  Retinoic acid beta receptor antagonist
0,034  0,020  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,025  0,010  Vitamin D receptor antagonist
0,018  0,004  Retinoic acid receptor gamma antagonist
0,087  0,074  Butyrylcholinesterase inhibitor
0,019  0,007  NMDA receptor phencyclidine site antagonist
0,137  0,126  ATPase inhibitor
0,056  0,046  Bombesin 1 receptor agonist
0,092  0,081  Hedgehog signaling inhibitor
0,021  0,010  Progesterone agonist
0,072  0,062  Narcotic antagonist
0,176  0,166  Renal disease treatment
0,023  0,014  Estrone sulfatase inhibitor
0,037  0,027  Delayed rectifier potassium channel blocker
0,194  0,185  Antithrombotic
0,131  0,122  Movement disorders treatment
0,041  0,032  Opioid kappa receptor agonist
0,100  0,092  Autism spectrum disorders treatment
0,074  0,068  Opioid kappa receptor antagonist
0,091  0,084  AMP-activated protein kinase stimulant
0,109  0,103  Antineoplastic (squamous cell carcinoma)
0,035  0,030  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,012  0,008  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,138  0,134  Antiviral (Hepatitis)
0,032  0,029  Tubulin agonist
0,016  0,014  Telomerase stimulant
0,132  0,129  Wound healing agent
0,064  0,062  SULT2A1 substrate
0,020  0,018  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,041  0,039  Microtubule stabilization
0,019  0,018  Corticosteroid-like
0,060  0,058  Uterine relaxant
0,078  0,076  Antineoplastic, alkylator
0,085  0,083  Dementia treatment
0,082  0,081  Vascular dementia treatment
0,015  0,014  Thyroid hormone alpha agonist

